نتائج البحث - Han, Shuiyun
- يعرض 1 - 10 نتائج من 10
-
1
-
2
Distinct Molecular Subtypes of Diffuse Large B Cell Lymphoma Patients Treated with Rituximab-CHOP Are Associated with Different Clinical Outcomes and Molecular Mechanisms حسب Yu, Haifeng, Peng, Shuailing, Han, Shuiyun, Chen, Xi, Lyu, Qinghua, Lei, Tao
منشور في 2021نص -
3
-
4
A Retrospective Comparison of Taxane and Fluorouracil-based Chemoradiotherapy in Patients with Inoperable Esophageal Squamous Cell Carcinoma حسب Sun, Xiaojiang, Han, Shuiyun, Gu, Feiying, Lin, Gang, Wang, Zhun, Wang, Yuezhen, Xu, Yaping
منشور في 2016نص -
5
The Prognostic Utility of (18)F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Analyses of Metabolic Response Rates in Newly Diagnosed Diffuse Large B Ce... حسب Li, Cong, Yu, Haifeng, Chen, Xi, Han, Shuiyun, Peng, Shuailing, Lei, Tao, Yang, Haiyan
منشور في 2022نص -
6
Prophylactic antibiotic treatment with TMP-SMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy حسب Li, Cong, Lu, Fangxiao, Lei, Tao, Yu, Haifeng, Chen, Xi, Peng, Shuailing, Han, Shuiyun, Yang, Haiyan
منشور في 2020نص -
7
A retrospective study of shrinking field radiation therapy during chemoradiotherapy in stage III non-small cell lung cancer حسب Jiang, Chenxue, Han, Shuiyun, Chen, Wucheng, Ying, Xiaozhen, Wu, He, Zhu, Yaoyao, Shi, Guodong, Sun, Xiaojiang, Xu, Yaping
منشور في 2018نص -
8
Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy... حسب Hu, Min, Xu, Qinghua, Yang, Shuangyan, Han, Shuiyun, Zhu, Yaoyao, Lin, Qingren, Sun, Xiaojiang, Liu, Hui, Xu, Yaping
منشور في 2020نص -
9
Bruton’s tyrosine kinase inhibitors in primary central nervous system lymphoma—evaluation of anti-tumor efficacy and brain distribution حسب Yu, Haifeng, Kong, Haiying, Li, Cong, Dong, Xiaowu, Wu, Yizhe, Zhuang, Yuxin, Han, Shuiyun, Lei, Tao, Yang, Haiyan
منشور في 2021نص -
10
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma حسب Chen, Xi, Kong, Haiying, Luo, Linxiang, Han, Shuiyun, Lei, Tao, Yu, Haifeng, Guo, Na, Li, Cong, Peng, Shuailing, Dong, Xiaowu, Yang, Haiyan, Wu, Meijuan
منشور في 2022نص